No Detail Found!

Enteric coating of nanostructured lipid carriers (NLCs) and enteric coating of hard gelatin capsules filled with NLCs: Feasibility studies

Author(s)
Renuka Suresh Managuli Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University,Manipal, Karnataka State,India
Meka Sreenivasa Reddy Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University,Manipal, Karnataka State,India
Kunnatur Balasundara Koteshwara Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University,Manipal, Karnataka State,India
Srinivas Mutalik Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University,Manipal, Karnataka State,India
Abstract
Nanostructured lipid carriers (NLCs) of asenapine maleate (ASPM) were enteric coated with polymethacrylate polymers (Eudragit®) for oral delivery. The present study aimed to compare the feasibility of direct enteric coating of NLCs and enteric coating of hard gelatin capsules filled with lyophilized ASPM-NLCs. Organic solution of Eudragit® was prepared using acetone containing 3% v/v water, acetone or ethanol. Aqueous dispersion of Eudragit® was obtained by neutralization with base. Capsules were enteric coated by dip-coating method with 3:2 ratio of Eudragit® L10055:S100 (7.5-12.5% w/v). ASPM-NLCs showed particle size of 84.91±2.14nm, polydispersity index of 0.222±0.026, entrapment efficiency of 86.9±1.8% and zeta potential of -4.83±0.29 mV. TEM images showed good sphericity of the particles with the size of ˜100nm. Non-aqueous enteric coating was not successful as NLCs were precipitated in organic solvent. Aqueous enteric coated ASPM-NLCs (lipid:coat=1:2) showed an increased size (150.8±16.7nm) and zeta potential (-23.5±2.2 mV) revealing the deposition of Eudragit®. However, aqueous enteric coated ASPM-NLCs and uncoated ASPM-NLCs showed higher drug release (18.3±3.1-22.3±3.2%) in HCl solution (pH 1.2) indicating no resistance offered by direct enteric coating of NLCs; whereas enteric coated capsules showed less drug release (4.7±0.8%) in HCl solution indicating sufficient gastric protection.
Publication Details
Page(s) 1323-1331
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: 4, Year: 2021

Request the full text from PASTIC

Keywords
Eudragit®, enteric coating, Asenapine maleate, Nanostructured lipid carriers, nano-carriers
0

Citations

0

Downloads

156

Views